# EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan -

**URL:** <https://schizophreniasupport.discourse.group/t/ea-pharma-announces-phase-3-trial-for-new-schizophrenia-treatment-in-japan/1415>\
**Category:** News on schizophrenia and mental health matters\
**Created:** [January 8, 2026, 5:47pm UTC](https://schizophreniasupport.discourse.group/t/ea-pharma-announces-phase-3-trial-for-new-schizophrenia-treatment-in-japan/1415 "2026-01-08T17:47:04Z")\
**Posts on this page:** 2\
**Page:** 1

<div class="post-metadata">

**Author:** ![everhopeful](https://yyz2.discourse-cdn.com/flex012/user_avatar/schizophreniasupport.discourse.group/everhopeful/32/605_2.png) [@everhopeful](https://schizophreniasupport.discourse.group/u/everhopeful)\
**Post date:** [January 8, 2026, 5:47pm UTC](https://schizophreniasupport.discourse.group/t/ea-pharma-announces-phase-3-trial-for-new-schizophrenia-treatment-in-japan/1415/1 "2026-01-08T17:47:04Z")

</div>

> **[EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan -...](https://pharmafile.com/news/ea-pharma-announces-phase-3-trial-for-new-schizophrenia-treatment-in-japan/)**
>
> EA Pharma, a subsidiary of Eisai, has announced the initiation of a phase 3 clinical trial of evenamide, a schizophrenia treatment, in Japan.

---

<div class="post-metadata">

**Author:** ![SzSupportAdmin](https://yyz2.discourse-cdn.com/flex012/user_avatar/schizophreniasupport.discourse.group/szsupportadmin/32/334_2.png) [@SzSupportAdmin](https://schizophreniasupport.discourse.group/u/SzSupportAdmin)\
**Post date:** [January 21, 2026, 10:50pm UTC](https://schizophreniasupport.discourse.group/t/ea-pharma-announces-phase-3-trial-for-new-schizophrenia-treatment-in-japan/1415/2 "2026-01-21T22:50:14Z")

</div>